top of page

Our Scientific Advisory Committee

WARPNINE has a scientific advisory committee comprised of representatives from medical oncology, gastroenterology, radiation oncology, upper GI surgery and palliative care. 


The purpose of the committee is to assess applications for funding of research into cancer biology and treatment. This includes translational research from laboratory to clinic / bedside, basic science research and clinical research with immediately relevant clinical trial funding that, in the opinion of the advisory board, will have a high chance of improving outcome soon for these cancers and that has been approved by an appropriate ethics committee. 


Dr Andrew Dean


  • Bachelor of Medicine and Surgery - MBChB MRCP (UK)

  • Fellow of the Royal Australasian College of Physicians - FRACP 

Andrew trained initially in Liverpool in the UK and obtained his membership of the College of Physicians in 1998. After immigrating to Australia, he continued his training in internal medicine and palliative care at Sir Charles Gairdner Hospital in Perth and Royal Prince Alfred Hospital in Sydney, becoming a fellow of the Royal Australian College of Physicians in 1993. On returning to Perth, Andrew established the palliative care service at Sir Charles Gairdner Hospital (SCGH) and St John of God Hospital (SJG) Subiaco, and was appointed professor of palliative medicine by ECU.


Driven by his passion to help patients with life-threatening illnesses, Andrew furthered his training in medical oncology and began working full-time as a medical oncologist in 2006. He is currently the head of the Department of Medical Oncology at SJG Subiaco and, at Genesis CancerCare at Shenton House in Joondalup. 

Andrew’s key areas of interest are upper gastrointestinal and gynaecological tumours. He has published articles on symptom control, novel therapies for ovarian and pancreatic cancer and the molecular profiling of solid tumours. He regularly participates in international clinical trials and continues to be a major contributor to pancreatic, lung and ovarian cancer studies.


Dr Mikael Johansson 

Upper GI/pancreatic surgeon, Consultant/Head of Department – Sir Charles Gairdner Hospital, Perth, WA


Assoc. Prof. Ian Yusoff  

Ass. Prof. Ian Yusoff is a gastroenterologist with subspecialty interests in pancreaticobiliary diseases. Procedurally, his main interests are in endoscopic ultrasound and pancreaticobiliary endoscopy. He is an integral part of the new endoscopic ultrasound service established at Hollywood in 2019. 

His specific interests are patients with pancreatitis, pancreatic cystic disease and pancreaticobiliary malignancy. Given the complex nature of these conditions, all patients are managed in a multidisciplinary context to ensure adherence to best practice evidence-based principles. 


He is actively involved in clinical research with specific interests in outcomes of endoscopy and technology assessment. 


Ass. Prof. Yusoff also has a public appointment at Sir Charles Gairdner Hospital and an adjunct appointment at The University of Western Australia as Clinical Associate Professor of Medicine. 


He is currently on a number of national advisory committees including the Cancer Council of Australia and the Royal Australasian College of Pathologists.


John McKenna


  • Degree of Bachelor of Nursing with Honours, The University of Liverpool, United Kingdom, 2004

  • Master of Science in Clinical Health Care Practice (Hons), Oxford Brooks University, United Kingdom, 2014

John started his nursing career in the José Carreras Bone Marrow Transplant Unit, Liverpool UK in 2004. After 3 years in bone marrow transplant and haematology, John moved to Oxford and was involved in the opening of the Oxford Cancer and Haematology Centre. 


He embarked in his Clinical Healthcare Practice Masters in 2010 and became the clinical lead and advanced nurse practitioner for a new UK Cancer and haematology rapid access helpline and assessment clinic based in Oxford. Through this time, John has developed a keen interest in advanced symptom and toxicity management and has developed a broad prescribing formulary. 


John emigrated to Perth Australia in July 2015 and was integral in the commissioning of the new Cancer and Haematology service at St John Of God Midland Public and Private Hospital. In January 2018, he joined WA Medical Oncology as Medical Oncology Nurse Practitioner for Dr Andrew Dean. John and Andrew continue to work collaboratively in the care of cancer patients undergoing a range of treatments including chemotherapy, immunotherapy, targeted biological therapies and clinical trials. John has completed further education in the management of treatment induced skin toxicities and continues to promote the role of nurse practitioners in cancer care development.

bottom of page